HC Deb 23 March 2000 vol 346 c629W
Miss McIntosh

To ask the Secretary of State for Health what provision his Department has made for research into and treatment of Crohn's disease. [114951]

Mr. Denham

We fund health and medical research in different ways. The Medical Research Council spent around £0.5 million on Crohn's disease in 1998–99. In addition we are currently commissioning, via the Health Technology Assessment Programme, a research project relevant to Crohn's disease, which will assess the impact of patient-centred disease management of inflammatory bowel disease.

Funding for the treatment of specific diseases is not separately identified in Health Authority or Primary Care Group allocations. Those commissioning healthcare will do so on the basis of local needs, in the context of priorities set nationally.

The treatment of patients with Crohn's disease is increasingly shared between gastroenterologists and General Practitioners. It may include following a special diet, dietary supplements, drug treatment with anti-inflammatory drugs, antibiotics and immunosuppressive drugs; and, in severe cases, surgery. Chronic inflammatory bowel disease is a risk factor for malignancy, and regular assessment is important.